Apyx Medical Corporation (APYX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 147.57M |
| Enterprise Value | 155.17M |
| P/E Ratio | -15.17 |
| PEG Ratio | -0.22 |
| Price/Sales Ratio | 2.12 |
| Price/Book Ratio | 13.9 |
| Enterprise/Revenue | 2.36 |
| Enterprise/EBITDA | -88.77 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.14 |
| Operating Margin | -0.06 |
| Return On Assets | -0.14 |
| Return On Equity | -0.71 |
| Revenue | 52.84M |
| Revenue/Share | 1.33 |
| Gross Profit | 19.03M |
| EBITDA | -4.59M |
| Net Income | -11.21M |
| Diluted EPS | -0.27 |
| Total Cash | 25.78M |
| Total Cash/Share | 0.58 |
| Total Debt | 39.75M |
| Total Debt/Equity | 4.13 |
| Current Ratio | 4.95 |
| Book Value Per Share | 0.22 |
| 52-Week Change | -30.72 |
| 52-Week High | 5.08 |
| 52-Week Low | 2.25 |
| Moving Average 50 Days | 2.73 |
| Moving Average 200 Days | 3.56 |
| Average Volume | 149,062 |
| Shares Outstanding | 42.12M |
| % Held by Institutions | 50.55 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |